Twitter
Google plus
Facebook
Vimeo
Pinterest

Fluid Edge Themes

Title Image

Invitra EV-OP™

Invitra Extracellular Vesicle Ophthalmic Solution

Invitra Extracellular Vesicle Ophthalmic Solution

Invitra Extracellular Vesicle Ophthalmic Solution (Invitra EV-OP) helps to restore the natural tear's lipid layer to hold in moisture and reduce tear evaporation.

Dedication to Excellence

Invitrx Therapeutics, headquartered in Orange County California is a global research-based biotechnology company with over 15 years of product development industry experience. Established in 2003, Invitrx Therapeutics has been a leading pioneer in Regenerative Stem Cell Therapies.

Quality Assurance

Invitra EV-OP™ and AF-OP™ is manufactured from umbilical cords from full-term deliveries. All donors are pre-screened and undergo comprehensive testing which includes the following:

  • Behavioral risk assessment
  • Physical assessment
  • Donor medical history
  • Communicable disease testing
Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.

Let’s Connect

We look forward to hearing from you! Please also feel free to contact us directly for assistance in finding physicians utilizing our innovative Invitra products.